Dr. Uğur Şahin, M.D., is a Turkish-German physician and scientist, the self-made billionaire Co-founder and CEO of BioNTech SE (NASDAQ: BNTX), the pioneering mRNA vaccine company. His career is rooted in elite medicine, scientific research, and entrepreneurial disruption.

Şahin holds an M.D. (Doctor of Medicine) degree from the University of Cologne and specialized in oncology and immunology. His philosophical approach centers on technological excellence, R&D intensity, and long-term commitment to mRNA technology (pioneering the next generation of personalized medicine). He co-founded BioNTech in 2008 with his wife, Özlem Türeci.

• BioNTech SE (Co-founder & CEO): The core publicly traded asset, the pioneering mRNA vaccine company (known for co-developing the Pfizer/BioNTech COVID-19 vaccine).
• Biotech Pioneer: His success is built on scale manufacturing and dominating the market for mRNA technology (a critical, rapidly growing medical platform).
• Academic Background: He holds an M.D. degree and specialized in oncology and immunology.
• Investment Strategy: His wealth is secured by his substantial equity stake in BioNTech, which surged dramatically due to the COVID-19 pandemic response.

Dr. Uğur Şahin's strategic genius was his commitment to the mRNA platform. He co-founded BioNTech in 2008 (focusing initially on personalized cancer immunotherapy). His structural contribution is immense: leading the development and rapid commercialization of the COVID-19 mRNA vaccine, a technology that fundamentally changed global public health policy and response and helped end the pandemic crisis.

He remains CEO, guiding the company's continuous innovation in mRNA therapeutics (for cancer, infectious diseases, and rare disorders). His wealth is secured by the colossal, long-term, stable profitability of the global biotechnology and healthcare sector.

Dr. Uğur Şahin's social impact is immense, stemming from BioNTech's role in developing and deploying the COVID-19 mRNA vaccine, which played a critical role in saving lives globally and demonstrating the power of platform medicine. His research advances personalized cancer treatment and global public health preparedness. He and his wife actively support various medical research and educational initiatives.

His personal philanthropy supports various community and educational initiatives.

Dr. Uğur Şahin maintains the professional, pragmatic style of a corporate executive. His attire is consistently formal and high-quality, favoring tailored suits. His aesthetic reflects serious authority and intellectual depth, typical of a pioneer in the global biotech sector.

Residing in Mainz, Germany, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to biotechnology innovation, strategic management, and scientific research.